Table 4.

Correlations of CSCs Markers Expression in LNM and Clinicopathological Data

	Average Expression (± Standard Error)
Variable	ALDH1	P	NANOG	P	Oct-4	P	CD133	P	CD44	P
Grading		P = .85		P = .051		P = .007		P = .035		P = .11
G1-2	10.16 (5.8-14.51)		45 (36.55-53.45)		1.48 (0.18-2.78)		0.43 (0.1-0.76)		9.59 (6.34-12.84)
G3	7.07 (3.58-10.55)		72.55 (65.99-79.11)		12.11 (5.83-18.39)		10.57 (5.06-16.08)		32.74 (24.23-41.24)
T stage		P = .60		P = .14		P = .76		P = .60		P = .049
T1	4.36 (0.81-7.90)		70.71 (60.95-80.48)		4.73 (1.56-7.91)		5.33 (0.35-10.32)		10.39 (3.32-17.47)
T2-4	10.72 (6.96-14.48)		50.58 (43.39-57.77)		7.14 (2.94-11.33)		3.61 (0.87-6.34)		23.21 (17.61-28.82)
ER status		P = .16		P = .04		P = .32		P < .001		P = .003
Negative	2.88 (0.39-5.38)		77.38 (68.59-86.16)		11.54 (3.69-19.39)		17.83 (8.63-27.04)		42.71 (31.57-53.84)
Positive	10.78 (7.1-14.45)		50.43 (43.53-57.33)		4.35 (1.44-7.26)		0.54 (0.18-0.90)		12.1 (8.14-15.97)
PR status		P = .27		P = .64		P = .15		P = .003		P = .009
Negative	8.28 (2.15-14.41)		61.23 (50.57-71.90)		12.33 (5.33-19.33)		14.2 (6.65-21.75)		34.97 (25.19-44.74)
Positive	8.99 (5.87-12.10)		55.47 (48.43-62.51)		3.57 (0.66-6.51)		0.62 (0.23-1.01)		12.79 (8.55-17.03)
HER2		P = .11		P = .87		P = .78		P = .83		P = .43
Negative	4.99 (2.70-7.27)		59.31 (52.39-66.23)		7.78 (3.47-12.04)		4.73 (1.84-7.62)		17.33 (12.31-22.35)
Positive	14.22 (7.13-21.3)		57 (46-68)		3.37 (1.03-5.70)		5.2 (0.21-10.19)		26.13 (16.90-35.37)
CTCs		P = .65		P = .032		P = .74		P = .80		P = .79
Negative	9 (4.29-13.71)		49.13 (40.71-57.55)		6.29 (1.96-10.62)		5.33 (1.96-8.71)		16.5 (10.53-22.47)
Positive	6.57 (2.41-10.72)		75.36 (65.7-85.01)		10.39 (3.06-17.72)		6.8 (0.82-12.78)		23.67 (14.4-32.93)